5-aminosalicylic acid inhibits colitis-a
β
Margie L. Clapper; Monique A. Gary; Renata A. Coudry; Samuel Litwin; Wen-Chi L.
π
Article
π
2008
π
John Wiley and Sons
π
English
β 304 KB
π 1 views
## Background: The impact of the antiinflammatory agent 5-aminosalicylic acid (5-ASA) on the risk for colitis-associated colorectal cancer remains controversial. The chemopreventive activity of 5-ASA was evaluated in the Swiss Webster model of azoxymethane (AOM)/dextran sulfate sodium (DSS)-induce